Capstone Triton Financial Group LLC Has $825,000 Position in The Clorox Company (NYSE:CLX)

Capstone Triton Financial Group LLC grew its position in The Clorox Company (NYSE:CLX) by 5.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,048 shares of the company’s stock after purchasing an additional 303 shares during the period. Capstone Triton Financial Group LLC’s holdings in Clorox were worth $825,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in CLX. Core Wealth Advisors Inc. acquired a new position in Clorox in the fourth quarter valued at about $29,000. Innealta Capital LLC acquired a new position in shares of Clorox in the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its position in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares during the last quarter. GoalVest Advisory LLC acquired a new stake in Clorox during the 1st quarter valued at $31,000. Finally, First Foundation Advisors bought a new position in Clorox in the 1st quarter valued at $31,000. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX opened at $163.33 on Friday. The stock has a market cap of $20.28 billion, a P/E ratio of 84.63, a price-to-earnings-growth ratio of 3.29 and a beta of 0.40. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09. The stock’s 50-day moving average price is $149.14 and its two-hundred day moving average price is $143.78. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. On average, equities analysts predict that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.51% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on CLX shares. DA Davidson restated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. Barclays raised their price objective on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. TD Cowen assumed coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price for the company. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to data from MarketBeat, Clorox currently has a consensus rating of “Hold” and a consensus target price of $143.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.